Innovid (CTV) Stock Forecast, Price & News

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Innovid in the last year. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" CTV shares.
View CTV analyst ratings or view top-rated stocks.

3 analysts have issued twelve-month price targets for Innovid's stock. Their CTV share price forecasts range from $1.40 to $5.00. On average, they predict the company's stock price to reach $3.35 in the next year. This suggests a possible upside of 179.2% from the stock's current price.
View analysts price targets for CTV or view top-rated stocks among Wall Street analysts.

Innovid's stock was trading at $1.71 at the beginning of the year. Since then, CTV shares have decreased by 29.8% and is now trading at $1.20.
View the best growth stocks for 2023 here.

Innovid saw a decline in short interest during the month of August. As of August 31st, there was short interest totaling 1,530,000 shares, a decline of 20.3% from the August 15th total of 1,920,000 shares. Based on an average daily trading volume, of 529,800 shares, the days-to-cover ratio is presently 2.9 days. Approximately 1.8% of the company's stock are sold short.
View Innovid's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Friday, November 10th 2023.
View our CTV earnings forecast.

Innovid Corp. (NYSE:CTV) posted its quarterly earnings results on Tuesday, August, 8th. The company reported ($0.03) EPS for the quarter, missing the consensus estimate of ($0.02) by $0.01. The firm earned $34.55 million during the quarter, compared to the consensus estimate of $32.90 million. Innovid had a negative trailing twelve-month return on equity of 14.09% and a negative net margin of 32.12%.

Innovid updated its third quarter 2023 earnings guidance on Tuesday, August, 8th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $33.00 million-$35.00 million, compared to the consensus revenue estimate of $32.80 million.

Innovid trades on the New York Stock Exchange (NYSE) under the ticker symbol "CTV."

Innovid's stock is owned by many different retail and institutional investors. Top institutional shareholders include Whetstone Capital Advisors LLC (2.60%), Royce & Associates LP (2.03%), Goldman Sachs Group Inc. (1.86%), Renaissance Technologies LLC (0.61%), Geode Capital Management LLC (0.53%) and State Street Corp (0.19%). Insiders that own company stock include David Helmreich, Gilad Shany, Tal Chalozin, Tanya Andreev-Kaspin and Zvika Netter.
View institutional ownership trends.

Shares of CTV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CTV stock can currently be purchased for approximately $1.20.

Innovid (NYSE:CTV) has a market capitalization of $167.16 million and generates $133.20 million in revenue each year. The company earns $-18,410,000.00 in net income (profit) each year or ($0.32) on an earnings per share basis.

The company employs 531 workers across the globe.

Innovid's mailing address is 89 MEDINAT HAYEHUDIM STREET, HERZLIYA L3, 4676672. The official website for the company is www.ion-am.com. The company can be reached via phone at 212-966-7555 or via email at investors@innovid.com.